A JAVMA study found poor-to-fair agreement between cytology and histopathology when classifying splenic masses or nodules in dogs as neoplastic or nonneoplastic.
Three quick summaries of the same article, tailored for different readers.
A JAVMA study found poor-to-fair agreement between cytology and histopathology when classifying splenic masses or nodules in dogs as neoplastic or nonneoplastic. A cytology result can narrow possibilities, but discordance with histopathology means clinicians should avoid giving a needle sample more certainty than the method can support. The study is useful context for a veterinary conversation, not a reason to change medication or treatment without the clinician managing the case.
The original source has the exact product, guidance, or study details behind the update.A JAVMA study found poor-to-fair agreement between cytology and histopathology when classifying splenic masses or nodules in dogs as neoplastic or nonneoplastic. The paper is a strong diagnostic-reasoning story because a minimally invasive sample can be useful without being definitive for a heterogeneous organ lesion. Intake details, medication history, sample quality, monitoring, and follow-up determine whether the finding can actually change a case workflow.
Open the source for the operational details, eligibility limits, methods, or workflow implications.A JAVMA study found poor-to-fair agreement between cytology and histopathology when classifying splenic masses or nodules in dogs as neoplastic or nonneoplastic. The paper is a strong diagnostic-reasoning story because a minimally invasive sample can be useful without being definitive for a heterogeneous organ lesion. The next step is to inspect the population, study design, comparator, endpoints, and limitations before deciding how far the result can be generalized.
The source is the best place to inspect the regulatory scope, study design, and limitations.